French Institute of Health and Medical Research-ko ikertzaileekin lankidetzan egindako argitalpenak (13)

2018

  1. Matrix metalloproteinase-10 deficiency delays atherosclerosis progression and plaque calcification

    Atherosclerosis, Vol. 278, pp. 124-134

2017

  1. New thrombolytic strategy providing neuroprotection in experimental ischemic stroke: MMP10 alone or in combination with tissue-type plasminogen activator

    Cardiovascular Research, Vol. 113, Núm. 10, pp. 1219-1229

  2. Recent progress in translational research on neurovascular and neurodegenerative disorders

    Restorative Neurology and Neuroscience, Vol. 35, Núm. 1, pp. 87-103

2014

  1. Targeting VEGFR1 on endothelial progenitors modulates their differentiation potential

    Angiogenesis, Vol. 17, Núm. 3, pp. 603-616

2013

  1. International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer

    Journal of Thrombosis and Haemostasis, Vol. 11, Núm. 1, pp. 56-70

  2. Pulmonary embolism and 3-month outcomes in 4036 patients with venous thromboembolism and chronic obstructive pulmonary disease: Data from the RIETE registry

    Respiratory Research, Vol. 14, Núm. 1

2012

  1. Synergistic effect of thrombin and CD40 ligand on endothelial matrix metalloproteinase-10 expression and microparticle generation in vitro and in vivo

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 32, Núm. 6, pp. 1477-1487

2011

  1. Matrix metalloproteinase-10 effectively reduces infarct size in experimental stroke by enhancing fibrinolysis via a thrombin-activatable fibrinolysis inhibitor-mediated mechanism

    Circulation, Vol. 124, Núm. 25, pp. 2909-2919

2010

  1. Arterial and venous thrombosis is associated with different angiogenic cytokine patterns in patients with antiphospholipid syndrome

    Lupus, Vol. 19, Núm. 7, pp. 837-843

  2. Immaturity of microvessels in haemorrhagic plaques is associated with proteolytic degradation of angiogenic factors

    Cardiovascular Research, Vol. 85, Núm. 1, pp. 184-193

2008

  1. Clinical predictors for fatal pulmonary embolism in 15 520 patients with venous thromboembolism: Findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) registry

    Circulation, Vol. 117, Núm. 13, pp. 1711-1716

2007

  1. Identification of soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) as a possible biomarker of subclinical atherosclerosis

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 27, Núm. 4, pp. 916-922

2002

  1. Bivalency of plasminogen monoclonal antibodies is required for plasminogen bridging to fibrin and enhanced plasmin formation

    Biochimica et Biophysica Acta - Protein Structure and Molecular Enzymology, Vol. 1598, Núm. 1-2, pp. 165-176